Related Experiment Videos
The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells
M T Webster1, B R Pearce, D M Bowen
1Dementia Research Laboratory, Biochemical Neuropharmacology Group, UMDS, London, United Kingdom.
Abstract:
The mismetabolism of amyloid precursor protein (APP), favouring the production of A beta, is considered to be central to the pathogenesis of Alzheimer's disease (AD). However it remains to be established whether the causative factor is the reported toxicity of A beta or reduced production of secretory derivatives of APP which may have trophic or neuroprotective properties. One possible contributory factor to an imbalance in APP metabolism is the impaired cellular energy availability described in AD. The aim of this study was to investigate processing of APP-like proteins following inhibition of oxidative energy metabolism in PC12 cells. Under these conditions, intracellular and secreted APP-like proteins were significantly reduced. Treatment of energy perturbed cells with the lysosomotropic agent chloroquine restored intracellular concentrations of APP-like proteins to the control range, while the secretion was completely restored by activation of protein kinase C. These findings raise the possibility that energy related metabolic stress may lead to altered metabolism of APP-like proteins favouring a potentially amyloidogenic pathway. Furthermore, the observation that activation of PKC is able to overcome this potentially pathogenic process has important implications for treatment of AD with the current generation of cholinomimetic drugs, suggesting that such drugs may slow disease progression as well as improve cognitive dysfunction.
Insights
Alzheimer
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) pathogenesis involves amyloid precursor protein (APP) metabolism, potentially linked to A beta toxicity or reduced neuroprotective APP derivatives.
- Impaired cellular energy metabolism is a characteristic feature of AD, possibly contributing to APP metabolism imbalance.
Purpose of the Study:
- To investigate the impact of inhibited oxidative energy metabolism on APP-like protein processing in PC12 cells.
- To explore potential therapeutic interventions for AD by examining the role of protein kinase C (PKC) and chloroquine.
Main Methods:
- PC12 cells were subjected to inhibited oxidative energy metabolism.
- APP-like protein levels (intracellular and secreted) were measured.
- Cells were treated with chloroquine and activators of protein kinase C (PKC).
Main Results:
- Inhibition of energy metabolism significantly reduced intracellular and secreted APP-like proteins.
- Chloroquine restored intracellular APP-like protein levels.
- PKC activation completely restored the secretion of APP-like proteins.
Conclusions:
- Energy-related metabolic stress may alter APP-like protein metabolism, potentially promoting an amyloidogenic pathway in Alzheimer's disease.
- PKC activation can counteract this potentially pathogenic process, suggesting a therapeutic strategy for AD.
- Cholinomimetic drugs, by potentially activating PKC, may slow AD progression and improve cognitive function.